NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

全球耳部感染治療市場研究報告:到2027年的預測

Global Ear Infection Treatment Market Research Report-Forecast till 2027

出版商 Market Research Future 商品編碼 990249
出版日期 內容資訊 英文 137 Pages
訂單完成後即時交付
價格
全球耳部感染治療市場研究報告:到2027年的預測 Global Ear Infection Treatment Market Research Report-Forecast till 2027
出版日期: 2020年12月17日內容資訊: 英文 137 Pages
簡介

2020年至2027年,全球耳部感染治療市場預計將以4.84%的複合年增長率增長,到2027年將達到19,370,240,000美元。

本報告調查了全球耳部感染治療市場,概述了市場,分析了市場影響因素,按細分/地區進行了詳細的分析和預測,競爭條件的分析以及主要公司的概況等等。

目錄

第1章執行摘要

第2章市場介紹

  • 調查範圍
  • 調查目的
  • 市場結構
  • 先決條件/限制

第3章調查方法

  • 數據挖掘
  • 二次調查
  • 初步調查
  • 主要受訪者細分
  • 預測方法
  • 市場規模估計的調查方法
  • 數據三角剖分
  • 驗證

第4章市場動態

  • 概述
  • 促進因素
    • 耳部感染率高
    • 政府在全球醫療保健方面的支出增加
    • 危險因素增加
    • 生長因子的影響分析
  • 抑製器
    • 手術風險和併發症
    • 細菌耐藥性的出現
    • 抑製器的影響分析
  • 市場機會
    • 耳部感染診斷和手術技術的進步

第5章市場因素分析

  • 價值鏈分析
  • 波特的五種力量模型
  • COVID-19的影響

第6章全球耳朵感染治療市場:按類型

  • 概述
  • 中耳
  • 外耳
  • 內耳

第7章:全球耳傳染病治療市場:按病原體分類

  • 概述
  • 細菌
  • 病毒

第8章:全球耳部感染治療市場:按治療方法

  • 概述
  • 手術
  • 藥物治療

第9章:全球耳部感染治療市場:按最終用戶分類

  • 概述
  • 醫院
  • 耳鼻喉科
  • 其他

第10章:全球耳傳染病治療市場:按地區

  • 概述
  • 美洲
    • 北美
    • 南美洲
  • 歐洲
    • 西歐
    • 東歐
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 中東/非洲
    • 中東
    • 非洲

第11章公司簡介

  • NOVARTIS INTERNATIONAL AG
    • 公司簡介
    • 財務概覽
    • 提供的產品/服務
    • 主要發展
    • SWOT分析
    • 主要策略
  • SANOFI S.A.
  • JANSSEN PHARMACEUTICALS
  • PFIZER INC.
  • ABBOTT LABORATORIES
  • SUN PHARMACEUTICAL INDUSTRIES LIMITED
  • BRISTOL-MYERS SQUIBB COMPANY
  • GLAXOSMITHKLINE PLC
  • DR. REDDY'S LABORATORIES LTD
  • GLENMARK PHARMACEUTICALS LIMITED

第12章附錄

  • 參考
  • 相關報告
目錄

Market Dynamics

Global Ear Infection Treatment Market is anticipated to witness a healthy CAGR of 4.84% during the review period of 2020 to 2027, to surpass USD 19,370.24 Million by 2027. An ear infection is a common health problem worldwide and is most common in young children and older people. The global market growth is attributed to the growing rate of incidences of ear infection treatment. According to WHO, the rate of incidences of ear infection occurs in children between the ages of 6 and 36 months, which is expected to fuel the global market. However, the disease is more common in the older population is further expected to contribute to the growth of the global market.

The global Ear Infection Treatment Market Research Report is anticipated to witness significant market growth during the review period. Additionally, the increasing rate of incidence has been propelling the growth of the ear infection treatment market in the last few years and is expected to command the market during the review period.

Market Segmentation

Global Ear Infection Treatment Market has been classified based on Type, Pathogen, Treatment, and End User.

Based on the type segment, the Global Ear Infection Treatment Market has been classified into the middle ear, outer ear, inner ear, and others.

This part is mostly affected by an ear infection. In terms of the pathogen, the global ear infection treatment market has been bifurcated into bacteria and viruses. The bacteria segment is contributed a larger market share during the review period owing to the growing ear infection due to bacteria.

The global ear infection treatment market, by treatment, has been categorized into medication and surgery. The medication segment dominated the market. In terms of end-use industry, the global market has been classified into hospitals, ENT clinics, and others.

Regional Analysis

Geographically, Global Ear Infection Treatment Market has been classified into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas has been classified into North America and Latin America, with the North American market further segmented into the US and Canada. The Americas is likely to command the market owing to the increasing prevalence of ear infection disease and product prevalence of ear infection disease and product innovation in the region.

The European ear infection treatment market has been classified into Western Europe and Eastern Europe. The Western Europe ear infection treatment market has further been segmented into Germany, France, the UK, Italy, Spain, and the Rest of Western Europe. Europe is expected to follow the Americas in terms of value during the review period due to the presence of supportive government initiatives, and research and development activities and, various marketing strategies by major market players.

Asia-Pacific is expected to register the fastest-growing market during the review period owing to the rising healthcare expenditure, expansion of enhanced healthcare facilities in China, India, and Australia, and increasing population suffering from ear infections.

Major Players

The Key Players in the Global Ear Infection Treatment Market include Novartis International AG. (Switzerland)., Sanofi S.A (France), Janssen Pharmaceutica (Belgium), Pfizer Inc (US), and Abbott Laboratories (US).

COVID 19 Impacts

We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

  • 2.1 SCOPE OF THE STUDY 16
  • 2.2 RESEARCH OBJECTIVE 16
  • 2.3 MARKET STRUCTURE 16
  • 2.4 ASSUMPTIONS & LIMITATIONS 17

3 RESEARCH METHODOLOGY

  • 3.1 DATA MINING 18
  • 3.2 SECONDARY RESEARCH 19
  • 3.3 PRIMARY RESEARCH 19
  • 3.4 BREAKDOWN OF PRIMARY RESPONDENTS 20
  • 3.5 FORECASTING TECHNIQUES 21
  • 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 22
    • 3.6.1 BOTTOM-UP APPROACH 23
    • 3.6.2 TOP-DOWN APPROACH 23
  • 3.7 DATA TRIANGULATION 24
  • 3.8 VALIDATION 24

4 MARKET DYNAMICS

  • 4.1 OVERVIEW 25
  • 4.2 DRIVERS 26
    • 4.2.1 HIGH RATE OF EAR INFECTIONS 26
    • 4.2.2 INCREASING EXPENDITURE BY GOVERNMENTS ACROSS THE WORLD TOWARDS HEALTHCARE 26
    • 4.2.3 RISE IN RISK FACTORS 26
    • 4.2.4 DRIVERS IMPACT ANALYSIS 27
  • 4.3 RESTRAINTS 27
    • 4.3.1 RISKS AND COMPLICATIONS OF SURGERY 27
    • 4.3.2 EMERGENCE OF BACTERIAL RESISTANCE 27
    • 4.3.3 RESTRAINTS IMPACT ANALYSIS 28
  • 4.4 OPPORTUNITIES 28
    • 4.4.1 TECHNOLOGICAL ADVANCEMENTS IN EAR INFECTION DIAGNOSIS AND SURGERY 28

5 MARKET FACTOR ANALYSIS

  • 5.1 VALUE CHAIN ANALYSIS 29
    • 5.1.1 R&D AND DESIGNING 30
    • 5.1.2 MANUFACTURING 30
    • 5.1.3 DISTRIBUTION 30
    • 5.1.4 MARKETING & SALES 30
  • 5.2 PORTER'S FIVE FORCES MODEL 31
    • 5.2.1 BARGAINING POWER OF SUPPLIERS 32
    • 5.2.2 BARGAINING POWER OF BUYERS 32
    • 5.2.3 THREAT OF NEW ENTRANTS 32
    • 5.2.4 THREAT OF SUBSTITUTES 32
    • 5.2.5 RIVALRY 32
  • 5.3 IMPACT OF COVID-19 33

6 GLOBAL EAR INFECTION TREATMENT MARKET, BY TYPE

  • 6.1 OVERVIEW 34
  • 6.2 MIDDLE EAR 35
  • 6.3 OUTER EAR 35
  • 6.4 INNER EAR 36

7 GLOBAL EAR INFECTION TREATMENT MARKET, BY PATHOGEN

  • 7.1 OVERVIEW 37
  • 7.2 BACTERIA 38
  • 7.3 VIRUS 38

8 GLOBAL EAR INFECTION TREATMENT MARKET, BY TREATMENT

  • 8.1 OVERVIEW 39
  • 8.2 SURGERY 40
  • 8.3 MEDICATION 41

9 GLOBAL EAR INFECTION TREATMENT MARKET, BY END USER

  • 9.1 OVERVIEW 43
  • 9.2 HOSPITALS 44
  • 9.3 ENT CLINICS 44
  • 9.4 OTHERS 44

10 GLOBAL EAR INFECTION TREATMENT MARKET, BY REGION

  • 10.1 OVERVIEW 45
  • 10.2 AMERICAS 47
    • 10.2.1 NORTH AMERICA 50
      • 10.2.1.1 US 53
      • 10.2.1.2 CANADA 55
    • 10.2.2 SOUTH AMERICA 57
  • 10.3 EUROPE 59
    • 10.3.1 WESTERN EUROPE 62
      • 10.3.1.1 GERMANY 65
      • 10.3.1.2 FRANCE 67
      • 10.3.1.3 UK 69
      • 10.3.1.4 ITALY 71
      • 10.3.1.5 SPAIN 73
      • 10.3.1.6 REST OF WESTERN EUROPE 75
    • 10.3.2 EASTERN EUROPE 77
  • 10.4 ASIA-PACIFIC 79
    • 10.4.1 CHINA 82
    • 10.4.2 JAPAN 84
    • 10.4.3 INDIA 86
    • 10.4.4 AUSTRALIA 88
    • 10.4.5 SOUTH KOREA 90
    • 10.4.6 REST OF ASIA-PACIFIC 92
  • 10.5 MIDDLE EAST AND AFRICA 94
    • 10.5.1 MIDDLE EAST 97
    • 10.5.2 AFRICA 99

11 COMPANY PROFILES

  • 11.1 NOVARTIS INTERNATIONAL AG 101
    • 11.1.1 COMPANY OVERVIEW 101
    • 11.1.2 FINANCIAL OVERVIEW 102
    • 11.1.3 PRODUCTS/SERVICES OFFERED 103
    • 11.1.4 KEY DEVELOPMENTS 103
    • 11.1.5 SWOT ANALYSIS 104
    • 11.1.6 KEY STRATEGIES 104

  • 11.2 SANOFI S.A. 105
    • 11.2.1 COMPANY OVERVIEW 105
    • 11.2.2 FINANCIAL OVERVIEW 106
    • 11.2.3 PRODUCTS/SERVICES OFFERED 106
    • 11.2.4 KEY DEVELOPMENTS 107
    • 11.2.5 SWOT ANALYSIS 107
    • 11.2.6 KEY STRATEGIES 108
  • 11.3 JANSSEN PHARMACEUTICALS 109
    • 11.3.1 COMPANY OVERVIEW 109
    • 11.3.2 FINANCIAL OVERVIEW 110
    • 11.3.3 PRODUCTS/SERVICES OFFERED 110
    • 11.3.4 KEY DEVELOPMENTS 111
    • 11.3.5 SWOT ANALYSIS 111
    • 11.3.6 KEY STRATEGIES 111
  • 11.4 PFIZER INC. 112
    • 11.4.1 COMPANY OVERVIEW 112
    • 11.4.2 FINANCIAL OVERVIEW 113
    • 11.4.3 PRODUCTS/SERVICES OFFERED 113
    • 11.4.4 KEY DEVELOPMENTS 114
    • 11.4.5 SWOT ANALYSIS 114
    • 11.4.6 KEY STRATEGIES 114
  • 11.5 ABBOTT LABORATORIES 115
    • 11.5.1 COMPANY OVERVIEW 115
    • 11.5.2 FINANCIAL OVERVIEW 116
    • 11.5.3 PRODUCTS/SERVICES OFFERED 116
    • 11.5.4 KEY DEVELOPMENTS 117
    • 11.5.5 SWOT ANALYSIS 117
    • 11.5.6 KEY STRATEGIES 117
  • 11.6 SUN PHARMACEUTICAL INDUSTRIES LIMITED 118
    • 11.6.1 COMPANY OVERVIEW 118
    • 11.6.2 FINANCIAL OVERVIEW 119
    • 11.6.3 PRODUCTS/SERVICES OFFERED 120
    • 11.6.4 KEY DEVELOPMENTS 120
    • 11.6.5 SWOT ANALYSIS 121
    • 11.6.6 KEY STRATEGIES 121

  • 11.7 BRISTOL-MYERS SQUIBB COMPANY 122
    • 11.7.1 COMPANY OVERVIEW 122
    • 11.7.2 FINANCIAL OVERVIEW 123
    • 11.7.3 PRODUCTS/SERVICES OFFERED 123
    • 11.7.4 KEY DEVELOPMENTS 123
    • 11.7.5 SWOT ANALYSIS 124
    • 11.7.6 KEY STRATEGIES 124
  • 11.8 GLAXOSMITHKLINE PLC 125
    • 11.8.1 COMPANY OVERVIEW 125
    • 11.8.2 FINANCIAL OVERVIEW 126
    • 11.8.3 PRODUCTS/SERVICES OFFERED 127
    • 11.8.4 KEY DEVELOPMENTS 127
    • 11.8.5 SWOT ANALYSIS 127
    • 11.8.6 KEY STRATEGIES 128
  • 11.9 DR. REDDY'S LABORATORIES LTD 129
    • 11.9.1 COMPANY OVERVIEW 129
    • 11.9.2 FINANCIAL OVERVIEW 130
    • 11.9.3 PRODUCTS/SERVICES OFFERED 130
    • 11.9.4 KEY DEVELOPMENTS 131
    • 11.9.5 SWOT ANALYSIS 131
    • 11.9.6 KEY STRATEGIES 131
  • 11.10 GLENMARK PHARMACEUTICALS LIMITED 132
    • 11.10.1 COMPANY OVERVIEW 132
    • 11.10.2 FINANCIAL OVERVIEW 133
    • 11.10.3 PRODUCTS/SERVICES OFFERED 134
    • 11.10.4 KEY DEVELOPMENTS 134
    • 11.10.5 SWOT ANALYSIS 135
    • 11.10.6 KEY STRATEGIES 135

12 APPENDIX

  • 12.1 REFERENCES 136
  • 12.2 RELATED REPORTS 136

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 17
  • TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 20
  • TABLE 3 GLOBAL EAR INFECTION TREATMENT MARKET, BY TYPE, 2017-2027 (USD MILLION) 34
  • TABLE 4 GLOBAL EAR INFECTION TREATMENT MARKET FOR MIDDLE EAR, BY REGION, 2017-2027 (USD MILLION) 35
  • TABLE 5 GLOBAL EAR INFECTION TREATMENT MARKET FOR OUTER EAR, BY REGION, 2017-2027 (USD MILLION) 35
  • TABLE 6 GLOBAL EAR INFECTION TREATMENT MARKET FOR INNER EAR, BY REGION, 2017-2027 (USD MILLION) 36
  • TABLE 7 GLOBAL EAR INFECTION TREATMENT MARKET, BY PATHOGEN, 2017-2027 (USD MILLION) 37
  • TABLE 8 GLOBAL EAR INFECTION TREATMENT MARKET FOR BACTERIA, BY REGION, 2017-2027 (USD MILLION) 38
  • TABLE 9 GLOBAL EAR INFECTION TREATMENT MARKET FOR VIRUS, BY REGION, 2017-2027 (USD MILLION) 38
  • TABLE 10 GLOBAL EAR INFECTION TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 39
  • TABLE 11 GLOBAL EAR INFECTION TREATMENT MARKET FOR SURGERY, BY REGION, 2017-2027 (USD MILLION) 40
  • TABLE 12 GLOBAL EAR INFECTION TREATMENT MARKET FOR MEDICATION, BY REGION, 2017-2027 (USD MILLION) 41
  • TABLE 13 GLOBAL EAR INFECTION TREATMENT MARKET FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 41
  • TABLE 14 GLOBAL EAR INFECTION TREATMENT MARKET FOR ANTIBIOTICS, BY TYPE, 2017-2027 (USD MILLION) 42
  • TABLE 15 GLOBAL EAR INFECTION TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 43
  • TABLE 16 GLOBAL EAR INFECTION TREATMENT MARKET FOR HOSPITALS, BY REGION, 2017-2027 (USD MILLION) 44
  • TABLE 17 GLOBAL EAR INFECTION TREATMENT MARKET FOR ENT CLINICS, BY REGION, 2017-2027 (USD MILLION) 44
  • TABLE 18 GLOBAL EAR INFECTION TREATMENT MARKET, BY REGION, 2017-2027 (USD MILLION) 46
  • TABLE 19 AMERICAS: EAR INFECTION TREATMENT MARKET, BY REGION, 2017-2027 (USD MILLION) 47
  • TABLE 20 AMERICAS: EAR INFECTION TREATMENT MARKET, BY TYPE, 2017-2027 (USD MILLION) 47
  • TABLE 21 AMERICAS: EAR INFECTION TREATMENT MARKET, BY PATHOGEN, 2017-2027 (USD MILLION) 48
  • TABLE 22 AMERICAS: EAR INFECTION TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 48
  • TABLE 23 AMERICAS EAR INFECTION TREATMENT MARKET FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 48
  • TABLE 24 AMERICAS EAR INFECTION TREATMENT MARKET FOR ANTIBIOTICS, BY TYPE, 2017-2027 (USD MILLION) 49
  • TABLE 25 AMERICAS: EAR INFECTION TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 49
  • TABLE 26 NORTH AMERICA: EAR INFECTION TREATMENT MARKET, BY COUNTRY, 2017-2027 (USD MILLION) 50
  • TABLE 27 NORTH AMERICA: EAR INFECTION TREATMENT MARKET, BY TYPE, 2017-2027 (USD MILLION) 50
  • TABLE 28 NORTH AMERICA: EAR INFECTION TREATMENT MARKET, BY PATHOGEN, 2017-2027 (USD MILLION) 51
  • TABLE 29 NORTH AMERICA: EAR INFECTION TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 51
  • TABLE 30 NORTH AMERICA EAR INFECTION TREATMENT MARKET FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 51
  • TABLE 31 NORTH AMERICA EAR INFECTION TREATMENT MARKET FOR ANTIBIOTICS, BY TYPE, 2017-2027 (USD MILLION) 52
  • TABLE 32 NORTH AMERICA: EAR INFECTION TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 52
  • TABLE 33 US: EAR INFECTION TREATMENT MARKET, BY TYPE, 2017-2027 (USD MILLION) 53
  • TABLE 34 US: EAR INFECTION TREATMENT MARKET, BY PATHOGEN, 2017-2027 (USD MILLION) 53
  • TABLE 35 US: EAR INFECTION TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 53
  • TABLE 36 US EAR INFECTION TREATMENT MARKET FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 54
  • TABLE 37 US EAR INFECTION TREATMENT MARKET FOR ANTIBIOTICS, BY TYPE, 2017-2027 (USD MILLION) 54
  • TABLE 38 US: EAR INFECTION TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 54
  • TABLE 39 CANADA: EAR INFECTION TREATMENT MARKET, BY TYPE, 2017-2027 (USD MILLION) 55
  • TABLE 40 CANADA: EAR INFECTION TREATMENT MARKET, BY PATHOGEN, 2017-2027 (USD MILLION) 55
  • TABLE 41 CANADA: EAR INFECTION TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 55
  • TABLE 42 CANADA EAR INFECTION TREATMENT MARKET FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 56
  • TABLE 43 CANADA EAR INFECTION TREATMENT MARKET FOR ANTIBIOTICS, BY TYPE, 2017-2027 (USD MILLION) 56
  • TABLE 44 CANADA: EAR INFECTION TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 56
  • TABLE 45 SOUTH AMERICA: EAR INFECTION TREATMENT MARKET, BY TYPE, 2017-2027 (USD MILLION) 57
  • TABLE 46 SOUTH AMERICA: EAR INFECTION TREATMENT MARKET, BY PATHOGEN, 2017-2027 (USD MILLION) 57
  • TABLE 47 SOUTH AMERICA: EAR INFECTION TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 57
  • TABLE 48 SOUTH AMERICA EAR INFECTION TREATMENT MARKET FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 58
  • TABLE 49 SOUTH AMERICA EAR INFECTION TREATMENT MARKET FOR ANTIBIOTICS, BY TYPE, 2017-2027 (USD MILLION) 58
  • TABLE 50 SOUTH AMERICA: EAR INFECTION TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 58
  • TABLE 51 EUROPE: EAR INFECTION TREATMENT MARKET, BY REGION, 2017-2027 (USD MILLION) 59
  • TABLE 52 EUROPE: EAR INFECTION TREATMENT MARKET, BY TYPE, 2017-2027 (USD MILLION) 59
  • TABLE 53 EUROPE: EAR INFECTION TREATMENT MARKET, BY PATHOGEN, 2017-2027 (USD MILLION) 60
  • TABLE 54 EUROPE: EAR INFECTION TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 60
  • TABLE 55 EUROPE EAR INFECTION TREATMENT MARKET FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 60
  • TABLE 56 EUROPE EAR INFECTION TREATMENT MARKET FOR ANTIBIOTICS, BY TYPE, 2017-2027 (USD MILLION) 61
  • TABLE 57 EUROPE: EAR INFECTION TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 61
  • TABLE 58 WESTERN EUROPE: EAR INFECTION TREATMENT MARKET, BY COUNTRY, 2017-2027 (USD MILLION) 62
  • TABLE 59 WESTERN EUROPE: EAR INFECTION TREATMENT MARKET, BY TYPE, 2017-2027 (USD MILLION) 63
  • TABLE 60 WESTERN EUROPE: EAR INFECTION TREATMENT MARKET, BY PATHOGEN, 2017-2027 (USD MILLION) 63
  • TABLE 61 WESTERN EUROPE: EAR INFECTION TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 63
  • TABLE 62 WESTERN EUROPE EAR INFECTION TREATMENT MARKET FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 64
  • TABLE 63 WESTERN EUROPE EAR INFECTION TREATMENT MARKET FOR ANTIBIOTICS, BY TYPE, 2017-2027 (USD MILLION) 64
  • TABLE 64 WESTERN EUROPE: EAR INFECTION TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 64
  • TABLE 65 GERMANY: EAR INFECTION TREATMENT MARKET, BY TYPE, 2017-2027 (USD MILLION) 65
  • TABLE 66 GERMANY: EAR INFECTION TREATMENT MARKET, BY PATHOGEN, 2017-2027 (USD MILLION) 65
  • TABLE 67 GERMANY: EAR INFECTION TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 65
  • TABLE 68 GERMANY EAR INFECTION TREATMENT MARKET FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 66
  • TABLE 69 GERMANY EAR INFECTION TREATMENT MARKET FOR ANTIBIOTICS, BY TYPE, 2017-2027 (USD MILLION) 66
  • TABLE 70 GERMANY: EAR INFECTION TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 66
  • TABLE 71 FRANCE: EAR INFECTION TREATMENT MARKET, BY TYPE, 2017-2027 (USD MILLION) 67
  • TABLE 72 FRANCE: EAR INFECTION TREATMENT MARKET, BY PATHOGEN, 2017-2027 (USD MILLION) 67
  • TABLE 73 FRANCE: EAR INFECTION TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 67
  • TABLE 74 FRANCE EAR INFECTION TREATMENT MARKET FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 68
  • TABLE 75 FRANCE EAR INFECTION TREATMENT MARKET FOR ANTIBIOTICS, BY TYPE, 2017-2027 (USD MILLION) 68
  • TABLE 76 FRANCE: EAR INFECTION TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 68
  • TABLE 77 UK: EAR INFECTION TREATMENT MARKET, BY TYPE, 2017-2027 (USD MILLION) 69
  • TABLE 78 UK: EAR INFECTION TREATMENT MARKET, BY PATHOGEN, 2017-2027 (USD MILLION) 69
  • TABLE 79 UK: EAR INFECTION TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 69
  • TABLE 80 UK EAR INFECTION TREATMENT MARKET FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 70
  • TABLE 81 UK EAR INFECTION TREATMENT MARKET FOR ANTIBIOTICS, BY TYPE, 2017-2027 (USD MILLION) 70
  • TABLE 82 UK: EAR INFECTION TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 70
  • TABLE 83 ITALY: EAR INFECTION TREATMENT MARKET, BY TYPE, 2017-2027 (USD MILLION) 71
  • TABLE 84 ITALY: EAR INFECTION TREATMENT MARKET, BY PATHOGEN, 2017-2027 (USD MILLION) 71
  • TABLE 85 ITALY: EAR INFECTION TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 71
  • TABLE 86 ITALY EAR INFECTION TREATMENT MARKET FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 72
  • TABLE 87 ITALY EAR INFECTION TREATMENT MARKET FOR ANTIBIOTICS, BY TYPE, 2017-2027 (USD MILLION) 72
  • TABLE 88 ITALY: EAR INFECTION TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 72
  • TABLE 89 SPAIN: EAR INFECTION TREATMENT MARKET, BY TYPE, 2017-2027 (USD MILLION) 73
  • TABLE 90 SPAIN: EAR INFECTION TREATMENT MARKET, BY PATHOGEN, 2017-2027 (USD MILLION) 73
  • TABLE 91 SPAIN: EAR INFECTION TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 73
  • TABLE 92 SPAIN EAR INFECTION TREATMENT MARKET FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 74
  • TABLE 93 SPAIN EAR INFECTION TREATMENT MARKET FOR ANTIBIOTICS, BY TYPE, 2017-2027 (USD MILLION) 74
  • TABLE 94 SPAIN: EAR INFECTION TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 74
  • TABLE 95 REST OF WESTERN EUROPE: EAR INFECTION TREATMENT MARKET, BY TYPE, 2017-2027 (USD MILLION) 75
  • TABLE 96 REST OF WESTERN EUROPE: EAR INFECTION TREATMENT MARKET, BY PATHOGEN, 2017-2027 (USD MILLION) 75
  • TABLE 97 REST OF WESTERN EUROPE: EAR INFECTION TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 75
  • TABLE 98 REST OF WESTERN EUROPE EAR INFECTION TREATMENT MARKET FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 76
  • TABLE 99 REST OF WESTERN EUROPE EAR INFECTION TREATMENT MARKET FOR ANTIBIOTICS, BY TYPE, 2017-2027 (USD MILLION) 76
  • TABLE 100 REST OF WESTERN EUROPE: EAR INFECTION TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 76
  • TABLE 101 EASTERN EUROPE: EAR INFECTION TREATMENT MARKET, BY TYPE, 2017-2027 (USD MILLION) 77
  • TABLE 102 EASTERN EUROPE: EAR INFECTION TREATMENT MARKET, BY PATHOGEN, 2017-2027 (USD MILLION) 77
  • TABLE 103 EASTERN EUROPE: EAR INFECTION TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 77
  • TABLE 104 EASTERN EUROPE EAR INFECTION TREATMENT MARKET FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 78
  • TABLE 105 EASTERN EUROPE EAR INFECTION TREATMENT MARKET FOR ANTIBIOTICS, BY TYPE, 2017-2027 (USD MILLION) 78
  • TABLE 106 EASTERN EUROPE: EAR INFECTION TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 78
  • TABLE 107 ASIA-PACIFIC: EAR INFECTION TREATMENT MARKET, BY COUNTRY, 2017-2027 (USD MILLION) 79
  • TABLE 108 ASIA-PACIFIC: EAR INFECTION TREATMENT MARKET, BY TYPE, 2017-2027 (USD MILLION) 80
  • TABLE 109 ASIA-PACIFIC: EAR INFECTION TREATMENT MARKET, BY PATHOGEN, 2017-2027 (USD MILLION) 80
  • TABLE 110 ASIA-PACIFIC: EAR INFECTION TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 80
  • TABLE 111 ASIA-PACIFIC EAR INFECTION TREATMENT MARKET FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 81
  • TABLE 112 ASIA-PACIFIC EAR INFECTION TREATMENT MARKET FOR ANTIBIOTICS, BY TYPE, 2017-2027 (USD MILLION) 81
  • TABLE 113 ASIA-PACIFIC: EAR INFECTION TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 81
  • TABLE 114 CHINA: EAR INFECTION TREATMENT MARKET, BY TYPE, 2017-2027 (USD MILLION) 82
  • TABLE 115 CHINA: EAR INFECTION TREATMENT MARKET, BY PATHOGEN, 2017-2027 (USD MILLION) 82
  • TABLE 116 CHINA: EAR INFECTION TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 82
  • TABLE 117 CHINA EAR INFECTION TREATMENT MARKET FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 83
  • TABLE 118 CHINA EAR INFECTION TREATMENT MARKET FOR ANTIBIOTICS, BY TYPE, 2017-2027 (USD MILLION) 83
  • TABLE 119 CHINA: EAR INFECTION TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 83
  • TABLE 120 JAPAN: EAR INFECTION TREATMENT MARKET, BY TYPE, 2017-2027 (USD MILLION) 84
  • TABLE 121 JAPAN: EAR INFECTION TREATMENT MARKET, BY PATHOGEN, 2017-2027 (USD MILLION) 84
  • TABLE 122 JAPAN: EAR INFECTION TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 84
  • TABLE 123 JAPAN EAR INFECTION TREATMENT MARKET FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 85
  • TABLE 124 JAPAN EAR INFECTION TREATMENT MARKET FOR ANTIBIOTICS, BY TYPE, 2017-2027 (USD MILLION) 85
  • TABLE 125 JAPAN: EAR INFECTION TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 85
  • TABLE 126 INDIA: EAR INFECTION TREATMENT MARKET, BY TYPE, 2017-2027 (USD MILLION) 86
  • TABLE 127 INDIA: EAR INFECTION TREATMENT MARKET, BY PATHOGEN, 2017-2027 (USD MILLION) 86
  • TABLE 128 INDIA: EAR INFECTION TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 86
  • TABLE 129 INDIA EAR INFECTION TREATMENT MARKET FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 87
  • TABLE 130 INDIA EAR INFECTION TREATMENT MARKET FOR ANTIBIOTICS, BY TYPE, 2017-2027 (USD MILLION) 87
  • TABLE 131 INDIA: EAR INFECTION TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 87
  • TABLE 132 AUSTRALIA: EAR INFECTION TREATMENT MARKET, BY TYPE, 2017-2027 (USD MILLION) 88
  • TABLE 133 AUSTRALIA: EAR INFECTION TREATMENT MARKET, BY PATHOGEN, 2017-2027 (USD MILLION) 88
  • TABLE 134 AUSTRALIA: EAR INFECTION TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 88
  • TABLE 135 AUSTRALIA EAR INFECTION TREATMENT MARKET FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 89
  • TABLE 136 AUSTRALIA EAR INFECTION TREATMENT MARKET FOR ANTIBIOTICS, BY TYPE, 2017-2027 (USD MILLION) 89
  • TABLE 137 AUSTRALIA: EAR INFECTION TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 89
  • TABLE 138 SOUTH KOREA: EAR INFECTION TREATMENT MARKET, BY TYPE, 2017-2027 (USD MILLION) 90
  • TABLE 139 SOUTH KOREA: EAR INFECTION TREATMENT MARKET, BY PATHOGEN, 2017-2027 (USD MILLION) 90
  • TABLE 140 SOUTH KOREA: EAR INFECTION TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 90
  • TABLE 141 SOUTH KOREA EAR INFECTION TREATMENT MARKET FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 91
  • TABLE 142 SOUTH KOREA EAR INFECTION TREATMENT MARKET FOR ANTIBIOTICS, BY TYPE, 2017-2027 (USD MILLION) 91
  • TABLE 143 SOUTH KOREA: EAR INFECTION TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 91
  • TABLE 144 REST OF ASIA-PACIFIC: EAR INFECTION TREATMENT MARKET, BY TYPE, 2017-2027 (USD MILLION) 92
  • TABLE 145 REST OF ASIA-PACIFIC: EAR INFECTION TREATMENT MARKET, BY PATHOGEN, 2017-2027 (USD MILLION) 92
  • TABLE 146 REST OF ASIA-PACIFIC: EAR INFECTION TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 92
  • TABLE 147 REST OF ASIA-PACIFIC EAR INFECTION TREATMENT MARKET FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 93
  • TABLE 148 REST OF ASIA-PACIFIC EAR INFECTION TREATMENT MARKET FOR ANTIBIOTICS, BY TYPE, 2017-2027 (USD MILLION) 93
  • TABLE 149 REST OF ASIA-PACIFIC: EAR INFECTION TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 93
  • TABLE 150 MIDDLE EAST & AFRICA: EAR INFECTION TREATMENT MARKET, BY REGION, 2017-2027 (USD MILLION) 94
  • TABLE 151 MIDDLE EAST & AFRICA: EAR INFECTION TREATMENT MARKET, BY TYPE, 2017-2027 (USD MILLION) 94
  • TABLE 152 MIDDLE EAST & AFRICA: EAR INFECTION TREATMENT MARKET, BY PATHOGEN, 2017-2027 (USD MILLION) 95
  • TABLE 153 MIDDLE EAST & AFRICA: EAR INFECTION TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 95
  • TABLE 154 MIDDLE EAST & AFRICA EAR INFECTION TREATMENT MARKET FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 95
  • TABLE 155 MIDDLE EAST & AFRICA EAR INFECTION TREATMENT MARKET FOR ANTIBIOTICS, BY TYPE, 2017-2027 (USD MILLION) 96
  • TABLE 156 MIDDLE EAST & AFRICA: EAR INFECTION TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 96
  • TABLE 157 MIDDLE EAST: EAR INFECTION TREATMENT MARKET, BY TYPE, 2017-2027 (USD MILLION) 97
  • TABLE 158 MIDDLE EAST: EAR INFECTION TREATMENT MARKET, BY PATHOGEN, 2017-2027 (USD MILLION) 97
  • TABLE 159 MIDDLE EAST: EAR INFECTION TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 97
  • TABLE 160 MIDDLE EAST: EAR INFECTION TREATMENT MARKET FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 98
  • TABLE 161 MIDDLE EAST: EAR INFECTION TREATMENT MARKET FOR ANTIBIOTICS, BY TYPE, 2017-2027 (USD MILLION) 98
  • TABLE 162 MIDDLE EAST: EAR INFECTION TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 98
  • TABLE 163 AFRICA: EAR INFECTION TREATMENT MARKET, BY TYPE, 2017-2027 (USD MILLION) 99
  • TABLE 164 AFRICA: EAR INFECTION TREATMENT MARKET, BY PATHOGEN, 2017-2027 (USD MILLION) 99
  • TABLE 165 AFRICA: EAR INFECTION TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 99
  • TABLE 166 AFRICA EAR INFECTION TREATMENT MARKET FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 100
  • TABLE 167 AFRICA EAR INFECTION TREATMENT MARKET FOR ANTIBIOTICS, BY TYPE, 2017-2027 (USD MILLION) 100
  • TABLE 168 AFRICA: EAR INFECTION TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 100
  • TABLE 169 NOVARTIS INTERNATIONAL AG: PRODUCTS/SERVICES OFFERED 103
  • TABLE 170 SANOFI S.A.: PRODUCTS/SERVICES OFFERED 106
  • TABLE 171 SANOFI S.A.: KEY DEVELOPMENTS 107
  • TABLE 172 JANSSEN PHARMACEUTICALS: PRODUCTS/SERVICES OFFERED 110
  • TABLE 173 JANSSEN PHARMACEUTICALS: KEY DEVELOPMENTS 111
  • TABLE 174 PFIZER INC.: PRODUCTS/SERVICES OFFERED 113
  • TABLE 175 ABBOTT LABORATORIES: PRODUCTS/SERVICES OFFERED 116
  • TABLE 176 SUN PHARMACEUTICAL INDUSTRIES LIMITED: PRODUCTS/SERVICES OFFERED 120
  • TABLE 177 BRISTOL-MYERS SQUIBB COMPANY: PRODUCTS/SERVICES OFFERED 123
  • TABLE 178 GLAXOSMITHKLINE PLC: PRODUCTS/SERVICES OFFERED 127
  • TABLE 179 DR. REDDY'S LABORATORIES LTD: PRODUCTS/SERVICES OFFERED 130
  • TABLE 180 DR. REDDY'S LABORATORIES LTD: KEY DEVELOPMENTS 131
  • TABLE 181 GLENMARK PHARMACEUTICALS LIMITED: PRODUCTS/SERVICES OFFERED 134
  • TABLE 182 GLENMARK PHARMACEUTICALS LIMITED: KEY DEVELOPMENTS 134

LIST OF FIGURES

  • FIGURE 1 MARKET SYNOPSIS 15
  • FIGURE 2 GLOBAL EAR INFECTION TREATMENT MARKET STRUCTURE 16
  • FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 22
  • FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL EAR INFECTION TREATMENT MARKET 25
  • FIGURE 5 MARET DRIVERS: ANALYSIS OF THE GLOBAL EAR INFECTION TREATMENT MARKET 27
  • FIGURE 6 MARKET RESTRAINTS: ANALYSIS OF THE GLOBAL EAR INFECTION TREATMENT MARKET 28
  • FIGURE 7 VALUE CHAIN: GLOBAL EAR INFECTION TREATMENT MARKET 29
  • FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL EAR INFECTION TREATMENT MARKET 31
  • FIGURE 9 GLOBAL EAR INFECTION TREATMENT MARKET, BY TYPE, 2019 AND 2027 (USD MILLION) 34
  • FIGURE 10 GLOBAL EAR INFECTION TREATMENT MARKET, BY PATHOGEN, 2019 AND 2027 (USD MILLION) 37
  • FIGURE 11 GLOBAL EAR INFECTION TREATMENT MARKET, BY TREATMENT, 2019 AND 2027 (USD MILLION) 39
  • FIGURE 12 GLOBAL EAR INFECTION TREATMENT MARKET, BY END USER, 2019 AND 2027 (USD MILLION) 43
  • FIGURE 13 GLOBAL EAR INFECTION TREATMENT MARKET, BY REGION, 2019 AND 2027 (USD MILLION) 46
  • FIGURE 14 AMERICAS: EAR INFECTION TREATMENT MARKET SHARE, BY REGION, 2019 (%) 47
  • FIGURE 15 NORTH AMERICA: EAR INFECTION TREATMENT MARKET SHARE, BY COUNTRY, 2019 (%) 50
  • FIGURE 16 EUROPE: EAR INFECTION TREATMENT MARKET SHARE, BY REGION, 2019 (%) 59
  • FIGURE 17 WESTERN EUROPE: EAR INFECTION TREATMENT MARKET SHARE, BY COUNTRY, 2019 (%) 62
  • FIGURE 18 ASIA-PACIFIC: EAR INFECTION TREATMENT MARKET SHARE, BY COUNTRY, 2019 (%) 79
  • FIGURE 19 MIDDLE EAST & AFRICA: EAR INFECTION TREATMENT MARKET SHARE, BY REGION, 2019 (%) 94
  • FIGURE 20 NOVARTIS INTERNATIONAL AG: FINANCIAL OVERVIEW SNAPSHOT 102
  • FIGURE 21 NOVARTIS INTERNATIONAL AG: SWOT ANALYSIS 104
  • FIGURE 22 SANOFI S.A.: FINANCIAL OVERVIEW SNAPSHOT 106
  • FIGURE 23 SANOFI S.A.: SWOT ANALYSIS 107
  • FIGURE 24 JANSSEN PHARMACEUTICALS: FINANCIAL OVERVIEW SNAPSHOT 110
  • FIGURE 25 JANSSEN PHARMACEUTICALS: SWOT ANALYSIS 111
  • FIGURE 26 PFIZER INC.: FINANCIAL OVERVIEW SNAPSHOT 113
  • FIGURE 27 PFIZER INC.: SWOT ANALYSIS 114
  • FIGURE 28 ABBOTT LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT 116
  • FIGURE 29 ABBOTT LABORATORIES: SWOT ANALYSIS 117
  • FIGURE 30 SUN PHARMACEUTICAL INDUSTRIES LIMITED: FINANCIAL OVERVIEW SNAPSHOT 119
  • FIGURE 31 SUN PHARMACEUTICAL INDUSTRIES LIMITED: SWOT ANALYSIS 121
  • FIGURE 32 BRISTOL-MYERS SQUIBB COMPANY: FINANCIAL OVERVIEW 123
  • FIGURE 33 BRISTOL-MYERS SQUIBB COMPANY: SWOT ANALYSIS 124
  • FIGURE 34 GLAXOSMITHKLINE PLC: FINANCIAL OVERVIEW SNAPSHOT 126
  • FIGURE 35 GLAXOSMITHKLINE PLC: SWOT ANALYSIS 127
  • FIGURE 36 DR. REDDY'S LABORATORIES LTD: FINANCIAL OVERVIEW SNAPSHOT 130
  • FIGURE 37 DR. REDDY'S LABORATORIES LTD: SWOT ANALYSIS 131
  • FIGURE 38 GLENMARK PHARMACEUTICALS LIMITED: FINANCIAL OVERVIEW SNAPSHOT 133
  • FIGURE 39 GLENMARK PHARMACEUTICALS LIMITED: SWOT ANALYSIS 135